BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 30585986)

  • 21. A case report of CBD and THC as analgesic therapy in a cat with chronic osteoarthritic pain.
    Gutierre E; Crosignani N; García-Carnelli C; di Mateo A; Recchi L
    Vet Med Sci; 2023 May; 9(3):1021-1025. PubMed ID: 37002652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single and combined effects of Δ
    King KM; Myers AM; Soroka-Monzo AJ; Tuma RF; Tallarida RJ; Walker EA; Ward SJ
    Br J Pharmacol; 2017 Sep; 174(17):2832-2841. PubMed ID: 28548225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
    Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
    Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaporized cannabis extract-induced antinociception in male vs female rats with persistent inflammatory pain.
    Craft RM; Gogulski HY; Freels TG; Glodosky NC; McLaughlin RJ
    Pain; 2023 Sep; 164(9):2036-2047. PubMed ID: 37027147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
    Boehnke KF; Gagnier JJ; Matallana L; Williams DA
    J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabidiol - an effective analgesic for toothache?
    Murphy S; Hayes E
    Evid Based Dent; 2024 Jun; 25(2):100-101. PubMed ID: 38649735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model.
    Mitchell VA; Harley J; Casey SL; Vaughan AC; Winters BL; Vaughan CW
    Neuropharmacology; 2021 May; 189():108529. PubMed ID: 33741405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
    Britch SC; Craft RM
    J Pain; 2023 Jan; 24(1):98-111. PubMed ID: 36122809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.
    Langford RM; Mares J; Novotna A; Vachova M; Novakova I; Notcutt W; Ratcliffe S
    J Neurol; 2013 Apr; 260(4):984-97. PubMed ID: 23180178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer-a study protocol for a randomised controlled trial.
    Gurgenci T; Hardy J; Huggett G; Foster K; Pelecanos A; Greer R; Philip J; Haywood A; Mendis R; Yates P; Good P
    Trials; 2024 May; 25(1):293. PubMed ID: 38693590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.
    Johnson JR; Burnell-Nugent M; Lossignol D; Ganae-Motan ED; Potts R; Fallon MT
    J Pain Symptom Manage; 2010 Feb; 39(2):167-79. PubMed ID: 19896326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.
    Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT
    Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients.
    Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model.
    Eeswara A; Pacheco-Spiewak A; Jergova S; Sagen J
    PLoS One; 2023; 18(3):e0282920. PubMed ID: 36913400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.
    Kayser RR; Haney M; Raskin M; Arout C; Simpson HB
    Depress Anxiety; 2020 Aug; 37(8):801-811. PubMed ID: 32383271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effects of Δ
    Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
    Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of cannabidiol (CBD) for the treatment of chronic pain.
    Urits I; Gress K; Charipova K; Habib K; Lee D; Lee C; Jung JW; Kassem H; Cornett E; Paladini A; Varrassi G; Kaye AD; Viswanath O
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):463-477. PubMed ID: 33004159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
    Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
    J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial.
    Almog S; Aharon-Peretz J; Vulfsons S; Ogintz M; Abalia H; Lupo T; Hayon Y; Eisenberg E
    Eur J Pain; 2020 Sep; 24(8):1505-1516. PubMed ID: 32445190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.
    Clarke S; Butcher BE; McLachlan AJ; Henson JD; Rutolo D; Hall S; Vitetta L
    PLoS One; 2022; 17(10):e0270543. PubMed ID: 36240167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.